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The Shc adaptor protein is highly phosphorylated at conserved,
twin tyrosine residues (Y239/240) that mediate protein–protein
interactions
Peter van der Geer*, Sandra Wiley*, Gerald D. Gish* and Tony Pawson*†
Background: Signal transduction initiated by a wide variety of extracellular
signals involves the activation of protein-tyrosine kinases. Phosphorylated
tyrosine residues in activated receptors or docking proteins then function as
binding sites for the Src homology 2 (SH2) or phosphotyrosine-binding (PTB)
domains of cytoplasmic signalling proteins. Shc is an adaptor protein that
contains both PTB and SH2 domains and becomes phosphorylated on tyrosine
in response to many different extracellular stimuli. These results have suggested
that Shc is a prominent effector of protein-tyrosine kinase signalling. Thus far,
only a single Shc phosphorylation site, the tyrosine at position 317 (Y317) has
been identified. Phosphorylation of Y317 has been implicated in Grb2 binding
and activation of the Ras pathway. 
Results: Here, we report the identification of two major and novel Shc tyrosine
phosphorylation sites, Y239 and Y240. These residues are present in the central
proline-rich (CH1) region and are conserved in all isoforms of Shc. Y239/240
are co-ordinately phosphorylated by the Src protein-tyrosine kinase in vitro, and
in response to epidermal growth factor stimulation or in v-src-transformed cells in
vivo. Mutagenesis studies indicate that Y239/240 make an important
contribution to the association of Shc with Grb2. Phosphopeptide-binding
studies suggest that these two tyrosine residues may be involved in interactions
with a number of cellular proteins. 
Conclusions: Shc is the most prominent general substrate for protein-tyrosine
kinases in vivo. The identification of two novel Shc phosphorylation sites
indicates that Shc has the potential to interact with multiple downstream
effectors. Shc Y239/240 are highly conserved in evolution, suggesting that the
phosphorylation of these residues is of fundamental importance. We propose
that distinct Shc phosphorylation isomers form different signalling complexes
and thereby activate separate downstream signalling cascades.
Introduction
Many different extracellular signals activate protein-tyro-
sine kinases [1–3], which in turn initiate cascades of
protein–protein interactions that lead to changes in gene
expression, cytoskeletal architecture and cell metabolism.
These protein–protein interactions are mediated by Src-
homology 2 (SH2) and phosphotyrosine-binding (PTB)
domains, which bind to specific tyrosine phosphorylation
sites [4–6].
The adaptor protein Shc contains an amino-terminal PTB
domain, a central proline-rich region (CH1), and a carboxy-
terminal SH2 domain [7]. The Shc PTB domain was recog-
nized recently as a protein module of approximately 160
amino-acid residues that binds to phosphotyrosine (pY) in
the context of specific amino-terminal residues, recogniz-
ing the sequence fXNPXpY (single-letter amino-acid
code; f indicates a large non-polar residue and X any
amino acid) [8–11]. Shc PTB-binding sites have been iden-
tified in a number of growth factor receptors [4,5], and two
potential Shc PTB-binding sites are present in the SHIP
inositol phosphatase [12–14]. The CH1 region of Shc
apparently provides a scaffold for further protein interac-
tions: the tyrosine at position 317 (Y317) is contained
within a binding site for the SH2 domain of Grb2, and
some stretches that are rich in proline residues may consti-
tute binding sites for Src-homology 3 (SH3) domains
[7,15,16]. The SH2 domain at the carboxyl terminus of Shc
binds, in vitro, to phosphorylated tyrosine residues in the
context of a large non-polar amino acid at the +3 position
[17], but physiological Shc SH2 domain-binding sites have
not been identified with certainty.
The Shc gene encodes three widely expressed proteins,
p46Shc, p52Shc and p66Shc, which differ only in the extent
of their amino-terminal sequences [7]. Two mammalian
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Shc-related polypeptides, ShcB (also known as Sck) and
ShcC, have been identified recently, and have been shown
to be expressed predominantly in the brain [9,18]. The
sequence conservation between different mammalian Shc
family members is highest within their PTB and SH2
domains [9,18]; the central CH1 region contains only three
short stretches of conserved amino acids, of which two
centre around tyrosine residues. One such conserved motif
(YYNS/DfPXKXPP) contains Y239 and Y240 of Shc, the
second motif (YVNXQ) includes the Shc Y317 phosphory-
lation site [7,15], and the third conserved motif, which
associates with adaptins, is predicted to form a turn [19]. A
Shc protein has also been identified recently in Drosophila
[20]. It is of interest to note that the CH1 residues homolo-
gous to Shc Y239 and Y240 are present in Drosophila Shc,
whereas the Shc Y317-containing motif is absent.
Shc polypeptides become phosphorylated on tyrosine and
serine residues in response to a wide variety of stimuli
[4,21]. Tyrosine-phosphorylated Shc can associate with
Grb2 [15,16,22], and through its association with the
Grb2/Sos complex may be linked to activation of the
Ras/MAP kinase pathway [23–27]. Our understanding of
Shc phosphorylation is limited to the characterization of
the Y317 phosphorylation site [15]. Y317 is present within
a consensus binding site for the Grb2 SH2 domain
(pYXNX) [17], and it is generally accepted that Grb2 asso-
ciates with Shc through Y317. Here, we have analyzed
tyrosine phosphorylation of Shc in detail and have identi-
fied Y239 and Y240 as two novel and major tyrosine phos-
phorylation sites. Our data indicate that these two
phosphotyrosine sites contribute significantly to the inter-
action of Shc with Grb2 following growth factor stimula-
tion. Furthermore, Y239 and Y240 may be involved in
binding several tyrosine-phosphorylated proteins. 
Results
Shc is co-ordinately phosphorylated at Y239 and Y240 by
v-Src in vitro
Shc becomes phosphorylated on tyrosine and serine
residues in response to numerous stimuli, suggesting that
its phosphorylation is of general importance for signal
transduction. Phosphoamino-acid analysis performed in the
initial study to characterize Shc phosphorylation in
response to epidermal growth factor (EGF) showed a spot
with a mobility different from phosphoserine, phospho-
threonine or phosphotyrosine [7]. To confirm this initial
observation, NIH3T3 cells overexpressing the EGF recep-
tor were labeled with 32P-orthophosphate and stimulated
with EGF; a similar 32P-labeling was undertaken with v-
src-transformed Rat-2 cells. Shc was isolated from these
cells and subjected to partial acid hydrolysis. Separation of
the hydrolysis products by electrophoresis in two dimen-
sions on thin-layer cellulose (TLC) plates showed the
presence of an additional radiolabeled spot that did not
correspond to any of the phosphorylated hydroxy-amino
acids (Fig. 1). The migration of this novel product sug-
gested that it may represent a dimer of two phosphory-
lated amino acids. This hydrolysis product was recovered
from the TLC plate and subjected to further acid hydroly-
sis and a subsequent round of phosphoamino-acid analy-
sis. Acid hydrolysis generated phosphotyrosine in addition
to the original compound (Fig. 1c), but not phosphoserine
or phosphothreonine, consistent with the possibility that
this hydrolysis product is composed of two phosphotyro-
sine residues.
Shc contains only one site with two neighbouring tyrosine
residues, at positions 239 and 240. Co-incident phosphory-
lation of these adjacent tyrosines within the same mole-
cule could generate a di-phosphopeptide. To test this
possibility, two glutathione S-transferase (GST)-fusion
proteins containing Shc residues 1–225 (GST–Shc1–225) or
1–307 (GST–Shc1–307) were phosphorylated in vitro using
purified v-Src kinase. As a potential substrate for protein-
tyrosine kinases, GST–Shc1–307 differs from GST–Shc1–225
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Figure 1
Acid hydrolysis of Shc isolated from in vivo 32P-labeled cells reveals a
product that does not comigrate with phosphoserine (P.Ser),
phosphothreonine (P.Thr), or phosphotyrosine (P.Tyr). Shc
polypeptides isolated from 32P-orthophosphate-labeled EGF-
stimulated HER14 or v-src-transformed fibroblasts were transferred to
PVDF membranes and hydrolyzed in hydrochloric acid. The hydrolysis
products were separated in the presence of P.Ser, P.Thr, and P.Tyr
markers by electrophoresis at pH 1.9 and pH 3.5 in two dimensions on
TLC plates. (a) Shc from EGF-stimulated cells. (b) Shc from v-src-
transformed cells. (c) Phosphoamino-acid analysis of the material
present in the extra spot shown in (b). (d) Schematic presentation of
the mobilities of the unlabeled phosphoamino-acid markers and the
extra spot following separation in two dimensions. P.Thr is shown in
white as no labeled P.Thr was detected in this experiment. 
(a)
(c)
(b)
(d)
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Extra
spot
P.Tyr
by the presence of only two additional tyrosine residues,
Y239 and Y240 (Fig. 2a). A fusion protein that contains
Shc Y317, but not Y239/240 (GST–Shc280–473), was used as
a control. GST–Shc1–307 was a better substrate for the Src
protein-tyrosine kinase than GST–Shc1–225, suggesting
that Y239 and Y240 may be good sites for phosphorylation
by v-Src (Fig. 2b,c). To test this possibility directly, Y239
and Y240 were mutated to phenylalanine, individually and
in combination, in the GST–Shc1–307 fusion protein. Sub-
stitution of both Y239 and Y240 with phenylalanine signif-
icantly reduced the extent of phosphorylation of the
GST–Shc1–307 fusion protein by v-Src (Fig. 2b,c). 
The GST–Shc1–225 and the GST–Shc1–307 fusion proteins
were phosphorylated with v-Src, resolved by SDS–PAGE
and isolated from the dried gel after autoradiography, and
were hydrolyzed for phosphoamino-acid analysis or
digested with trypsin for phosphopeptide mapping. Phos-
phoamino-acid analysis showed that phosphorylated
GST–Shc1–307 had the novel extra spot whereas phospho-
rylated GST–Shc1–225 did not (Fig. 3). The intensity of the
extra spot was low following phosphorylation by Src in
vitro — this may be caused by low stoichiometry of phos-
phorylation in vitro, or may indicate that the singly phos-
phorylated site is a poor substrate for Src. Substitution of
either Y239 or Y240 with phenylalanine resulted in disap-
pearance of the extra spot in the phosphoamino-acid
analysis (Fig. 3), further suggesting that the novel spot
represents a dipeptide containing phosphorylated tyrosine
residues 239 and 240.
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Figure 2
The amino-terminal half of Shc contains sites for phosphorylation by
the Src protein-tyrosine kinase in vitro. (a) Schematic representation of
the different fusion proteins used in this study; the sequence around
Y239 and Y240 in different members of the Shc family is also shown.
(b) Different GST fusion proteins were incubated with purified v-Src
protein-tyrosine kinase in the presence of g-[32P]ATP and divalent
cations. Phosphorylated proteins were resolved by SDS–PAGE, the
gel was stained and dried, and phosphorylated proteins were
visualized by autoradiography. Lane 1: GST; lane 2: GST–Shc1–225;
lane 3: GST–Shc1–307; lane 4: GST–Shc1–307F239; 
lane 5: GST–Shc1–307F240; lane 6: GST–Shc1–3072F; 
lane 7: GST–Shc280–473. (c) Coomassie blue staining of a gel
containing identical amounts of the proteins analyzed in (b). 
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Figure 3
Phosphorylation of Y239 and Y240 by Src in vitro gives rise to the extra
spot seen in phosphoamino-acid analysis of tyrosine phosphorylated
Shc isolated from v-src-transformed cells. In vitro phosphorylated
GST–Shc fusion proteins isolated from the gel shown in Figure 2b
were hydrolyzed in hydrochloric acid; hydrolysis products were
separated by electrophoresis at pH 1.9 and 3.5 in two dimensions on
TLC plates and visualized by autoradiography in the presence of an
intensifier screen. (a) GST–Shc1–225. (b) GST–Shc1–307. 
(c) GST–Shc1–307F239. (d) GST–Shc1–307F240. 
(a) (b)
(c) (d)
P.TyrP.Tyr
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Shc1–225 Shc1–307
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Phosphopeptide mapping of the two GST fusion proteins
phosphorylated in vitro by v-Src showed that GST–Shc1–307
contained a phosphopeptide that was missing in phospho-
rylated GST–Shc1–225 (Fig. 4a,b). This phosphopeptide
migrated in the same position as a major phosphopeptide
present in tryptic digests of in vivo 32P-labeled p46Shc iso-
lated from v-src transformed cells (Fig. 4d). Substitution of
both Y239 and Y240 with phenylalanine resulted in disap-
pearance of the phosphopeptide unique to GST–Shc1–307
(Fig. 4c). These data add support to the idea that Y239 and
240 are phosphorylated by v-Src in vitro, and suggest that
these sites are also phosphorylated in vivo. 
Y239 and Y240 are highly phosphorylated by v-Src and
the activated EGF receptor in vivo
To study Shc phosphorylation in vivo, the mutations
affecting Y239 and Y240 were introduced into a cDNA
encoding the full-length 52 kDa isoform of Shc with an
haemagglutinin (HA) epitope at the amino terminus.
Wild-type, F239, F240 and F239/240 (2F) mutant proteins
were then expressed by transient transfection in COS1
cells. To compare the phosphorylation of the wild-type
and mutant Shc proteins, the COS1 cells were co-trans-
fected with a v-src expression vector. Analysis of anti-HA
immunoprecipitates by immunoblotting with an anti-Shc
polyclonal antiserum, showed that wild-type and mutant
Shc proteins were expressed at very similar levels in trans-
fected cells (Fig. 5a). Immunoblotting of parallel HA-
immunoprecipitates with a polyclonal anti-phosphotyrosine
antiserum showed that wild-type protein was highly tyro-
sine-phosphorylated in these v-Src-expressing COS1 cells
(Fig. 5b). However, the 2F mutant Shc contained consider-
ably lower levels of phosphotyrosine, and the single
mutants F239 and F240 showed intermediate levels of tyro-
sine phosphorylation. These data indicate that both Y239
and Y240 are phosphorylated in cells expressing the v-Src
cytoplasmic protein-tyrosine kinase.
To study phosphorylation of these Shc proteins in
response to activation of a receptor protein-tyrosine
kinase, COS1 cells were transiently transfected with the
Shc expression constructs, starved for 24 hours in serum-
free medium and stimulated with EGF for 5 minutes at
37 °C. Wild-type and mutant Shc proteins were expressed
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Figure 4
GST–Shc1–307 phosphorylated in vitro by Src and p46Shc isolated from
Src-transformed cells have a tryptic phosphopeptide in common.
GST–Shc fusion proteins phosphorylated in vitro by purified Src (see
Fig. 2b), and p46Shc isolated by immunoprecipitation from 32P-labeled
v-src-transformed fibroblasts, were isolated from the gel and digested
with trypsin. The digestion products were separated in two dimensions
by electrophoresis at pH 1.9 and chromatography in phosphochromato-
graphy buffer on TLC plates. Phosphopeptides were visualized by
autoradiography in the presence of an intensifier screen. 
(a) GST–Shc1–225 phosphorylated in vitro by Src. (b) GST–Shc 1–307
phosphorylated in vitro by Src. (c) GST–Shc1–3072F phosphorylated in
vitro by Src. (d) p46Shc isolated from 32P-labeled v-src-transformed cells.
(a) (b)
(c) (d)
Shc1–225 Shc1–307
Shc1–3072F p46Shc
Figure 5
Mutation of Y239 and Y240 to phenylalanine results in decreased
tyrosine phosphorylation of Shc in v-Src-expressing COS1 cells. HA-
tagged wild-type and mutant Shc proteins were co-expressed with v-
Src by transient transfection in COS1 cells. Shc proteins were isolated
by immunoprecipitation with an anti-HA monoclonal antibody and
analyzed by immunoblotting with (a) an anti-Shc polyclonal serum and
(b) an anti-pY polyclonal serum. The gels show anti-HA immuno-
precipitates from COS1 cells transiently expressing v-Src (lane 1),
wild-type HA–Shc and v-Src (lane 2), HA–ShcF239 and v-Src (lane
3), HA–ShcF240 and v-Src (lane 4), or HA–Shc2F and v-Src (lane 5).
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at very similar levels (Fig. 6a). Anti-phosphotyrosine blot-
ting of anti-HA immunoprecipitates showed strong tyro-
sine phosphorylation of the wild-type Shc protein in
response to EGF. In contrast, the 2F mutant was more
weakly tyrosine phosphorylated and the single F239 and
F240 mutants were phosphorylated to intermediate levels,
as also observed in the v-Src-expressing cells. Wild-type
and mutant proteins showed equivalent association with
the activated EGF receptor (Fig. 6b). Phosphoamino-acid
analysis of HA-tagged Shc proteins (labeled with 32P in
vivo) isolated from EGF-stimulated COS1 cells showed
that mutant proteins with both Y239 and Y240 substituted
with phenylalanine lacked the extra spot characteristic of
wild-type Shc. These data indicate that Y239 and Y240 are
major in vivo sites of phosphorylation in response to growth
factor stimulation. Furthermore, the prominent representa-
tion of the di-phosphopeptide in acid hydrolysates of Shc
phosphorylated in vivo suggests that both tyrosines are
commonly phosphorylated in the same molecule.
The relative extent to which Shc was phosphorylated at
either Y239/240 or Y317 was directly compared by tran-
siently expressing HA-tagged wild-type or mutant proteins
in COS1 cells. Substitution of Y317 with phenylalanine
resulted in a decrease in EGF-induced Shc tyrosine phos-
phorylation. However, substitution of Y239/240 caused a
more marked reduction in the EGF-induced tyrosine
phosphorylation of Shc than did substitution of Y317 (Fig.
7b). These data indicate that Y239/240, as well as Y317, are
important Shc phosphorylation sites.
Phosphorylation of Shc Y239/240 induces binding of
cellular proteins 
A likely function of the Y239/240 phosphorylation sites is
to provide binding sites for modules that recognize phos-
photyrosine, such as SH2 or PTB domains. Examination of
the amino-acid sequence around these sites showed that
Y239 is present within a consensus binding sequence for
the Grb2 SH2 domain, pYXNX [17], and might therefore
interact with Grb2. To test this possibility, 12-amino acid
peptides based on the sequence around Y239 and Y240
(residues 236–247) were tested for their ability to bind to
Grb2. The unphosphorylated peptide (YY), peptides phos-
phorylated on either Y239 or Y240 (pY-Y and Y-pY, respec-
tively), and the doubly phosphorylated peptide (pY-pY)
were biotinylated, immobilized on Streptavidin-agarose
and incubated with cell lysates from v-Src-expressing
fibroblasts. Bound proteins were analyzed by anti-Grb2
immunoblotting. Peptides phosphorylated on Y239 and
peptides phosphorylated on both Y239 and Y240 bound to
Grb2 present in these cell lysates (Fig. 8a), whereas
unphosphorylated peptides or peptides phosphorylated on
Y240 did not.
To extend this analysis to full-length Shc, lysates from
control and EGF-stimulated COS1 cells expressing wild-
type and mutant HA-tagged Shc proteins were incubated
with immobilized GST–Grb2 SH2 domain fusion proteins.
In this experiment, wild-type HA-tagged Shc from EGF-
stimulated cells bound strongly to the Grb2 SH2 domain in
vitro, whereas the single or double mutant proteins with
substitutions at Y239/240 bound significantly less well (Fig.
8b). To test for association of Grb2 with HA-tagged Shc in
vivo, HA immunoprecipitates from transiently transfected
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Figure 6
Y239 and Y240 are major sites of Shc phosphorylation in EGF-
stimulated COS1 cells. Transiently expressed wild-type and mutant
HA-tagged Shc proteins were isolated by immunoprecipitation with an
anti-HA monoclonal antibody from control and EGF-stimulated COS1
cells and analyzed by immunoblotting with (a) an anti-Shc polyclonal
serum and (b) an anti-pY polyclonal serum. The gels show anti-HA
immunoprecipitates from serum-starved control (lanes 1,3,5,7) and
EGF-stimulated (lanes 2,4,6,8,9) COS1 cells transiently expressing
wild-type HA–Shc (lanes 1,2), HA–ShcF239 (lanes 3,4),
HA–ShcF240 (lanes 5,6), or HA–Shc2F (lanes 7,8), or from COS1
cells transfected with an empty expression vector (lane 9). (c)
Transiently expressed wild-type and 2F mutant HA–Shc proteins were
isolated from 32P-labeled EGF-stimulated COS1 cells and hydrolyzed
in hydrochloric acid. The hydrolysis products were separated in the
presence of unlabeled markers by electrophoresis in two dimensions
at pH 1.9 and pH 3.5 on TLC plates. Phosphoamino acids were
visualized by autoradiography in the presence of an intensifier screen.
The spot containing the Y239/240 di-phosphopeptide is indicated
with an arrow.
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control and EGF-stimulated COS1 cells were analyzed by
anti-Grb2 immunoblotting. Grb2 was easily detected in HA
immunoprecipitates from EGF-stimulated COS1 cells
expressing the wild-type HA-tagged Shc protein. The
F239 and F240 single, and the 2F double mutant proteins
coprecipitated significantly less Grb2, consistent with a
model in which the twin tyrosine residues constitute a
major Grb2 binding site in Shc (Fig. 8c). 
The relative involvement of Y239/240 and Y317 in Grb2-
binding were then compared directly. Whereas mutation
of Y317 moderately reduced binding of HA-tagged Shc to
Grb2 following EGF stimulation, the substitution of
Y239/240 with phenylalanines resulted in a large decrease
in Grb2 binding (Fig. 7c). These data suggest that, while
the Y239/240 and Y317 sites both interact with Grb2,
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Figure 7
Both Y239/240 and Y317 are major Shc phosphorylation sites.
Transiently expressed wild-type and mutant HA-tagged Shc
polypeptides were immunoprecipitated with an anti-HA antibody and
immunoblotted with anti-Shc (a), anti-pY (b) and anti-Grb2 (c) sera. The
gels show anti-HA immunoprecipitates from serum-starved (lanes 1,3,5)
and EGF-stimulated (lanes 2,4,6,7) COS1 cells expressing wild-type
HA–Shc (lanes 1,2), HA–Shc2F (lanes 3,4), or HA–ShcF317 (lanes
5,6), or from cells containing the empty expression vector (lane 7).
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Figure 8
Phosphorylation of Shc at Y239 and Y240 forms a binding site for the
Grb2 SH2 domain. (a) Biotinylated phosphopeptides based on the
sequence around Y239 and Y240 were immobilized on streptavidin–
Sepharose and incubated with lysates from v-src-transformed
fibroblasts. Bound proteins were analyzed by immunoblotting with an
anti-Grb2 polyclonal serum; lysates were incubated with
unphosphorylated peptide (Y-Y, lane 1), a peptide phosphorylated on
Y239 (pY-Y, lane 2), a peptide phosphorylated on Y240 (Y-pY, lane 3)
and a peptide phosphorylated on both tyrosine residues (pY-pY, lane
4). (b) Lysates from serum-starved control (lanes 1,3,5,7) or EGF-
stimulated (lanes 2,4,6,8) COS1 cells transiently expressing HA-
tagged wild-type or mutant Shc proteins were incubated with
GST–Grb2 SH2 fusion proteins immobilized on glutathione–
Sepharose. Bound proteins were analyzed by anti-HA immunoblotting.
Lysates were from cells expressing wild-type Shc (lanes 1,2),
ShcF239 (lanes 3,4), ShcF240 (lanes 5,6), or Shc2F (lanes 7,8). (c)
HA immunoprecipitates from serum-starved control (lanes 1,3,5,7) and
EGF-stimulated (lanes 2,4,6,8,9) COS1 cells transiently expressing
HA-tagged wild-type or mutant Shc proteins were analyzed by
immunoblotting with an anti-Grb2 polyclonal serum. Lysates were from
cells expressing wild-type Shc (lanes 1,2), ShcF239 (lanes 3,4),
ShcF240 (lanes 5,6), or Shc2F (lanes 7,8), or from cells transfected
with an empty expression vector (lane 9).
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Y239/240 is the major Grb2 binding site in the cells ana-
lyzed here. Consistent with this possibility, quantitative
analysis has shown that the di-phosphorylated Y239/240
peptide binds the Grb2 SH2 domain with a five-fold
greater affinity than a phosphopeptide containing the
Y317 site (our unpublished results).
To test whether these phosphorylation sites could be
involved in interactions with proteins other than Grb2, we
used the phosphotyrosine-containing peptides based on
the sequence around Y239 and Y240 as affinity reagents.
Immobilized peptides were incubated with cell lysates of
v-Src expressing cells and bound proteins were eluted and
analyzed by anti-phosphotyrosine blotting. Unphosphory-
lated peptides or peptides phosphorylated on Y240 did not
specifically bind any phosphotyrosine-containing proteins.
Peptides phosphorylated on Y239 or phosphorylated on
both Y239 and Y240 bound to a number of tyrosine phos-
phorylated proteins. We reproducibly observed binding of
proteins with molecular weights of ~22, ~40 and
~160 kDa. Interestingly, the peptide phosphorylated
singly on Y239 appeared to bind to p40 with greater affin-
ity than the doubly phosphorylated peptide; in contrast,
the doubly phosphorylated peptide appeared to bind with
greater affinity to p22 and p160 (Fig. 9). These data
suggest that Shc may change binding partners depending
on the phosphorylation status of Y239 and Y240. 
Discussion 
A wealth of data suggest that the phosphorylation of Shc is
an important step in signal transduction initiated by a wide
variety of extracellular stimuli. Y317, located in the carboxy-
terminal half of the central CH1 region of Shc, has been
identified previously as an important site of phosphorylation
[7,15]. Here, we have analyzed Shc phosphorylation and
have identified Y239 and Y240 as two additional phosphory-
lation sites. A combination of phosphopeptide mapping,
phosphoamino-acid analysis, and site-directed mutagenesis
have shown that Y239 and Y240 are principal sites of Shc
phosphorylation by v-Src in vitro, and by v-Src and the acti-
vated EGF receptor in vivo. Identification of a di-phospho-
peptide containing phosphorylated Y239/240 indicates that
both sites are efficiently phosphorylated within individual
Shc molecules, for example in EGF-stimulated cells. The
remaining tyrosine phosphorylation observed when Y239
and Y240 are both changed to phenylalanine can be
accounted for by phosphorylation at Y317. Consistent with
our results, previous work indicated that a full-length
mutant Shc protein with phenylalanine at residue 317 could
still be phosphorylated on tyrosine in vivo [15].
We have compared the sequence around Y239/240 of Shc
with the corresponding sequences in the ShcB and ShcC
polypeptides [9,18]. Both tyrosine residues and the sur-
rounding amino-acid sequences are conserved between
the three mammalian Shc family members (Fig. 1). The
sequence relationship amino-terminal to the twin tyrosine
residues is limited to the presence of acidic amino-acid
residues that may be involved in recognition by protein-
tyrosine kinases. Sequence conservation is quite extensive
within the 18 residues carboxy-terminal to the adjacent
tyrosines, suggesting that the function of Y239 and Y240 is
conserved between the Shc family members. It is intrigu-
ing that the sequence conservation extends considerably
beyond the 3–5 residues needed to provide a binding
surface for an SH2 domain [17,28], suggesting that multi-
ple functions may be performed by this island of con-
served amino-acid residues. Two adjacent tyrosine
residues are also present in Drosophila Shc, and are found
within a YYNDXPXKXPP motif which is conserved
between the human and the Drosophila polypeptides. This
is in contrast to Y317, which is not found in Drosophila Shc
[20] — suggesting that the function of Y239 and 240 has
been established early in evolution and may be conserved
between Drosophila and man, whereas the function of
Y317 may have evolved more recently.
Y239 is present within the context of a Grb2 SH2 domain
consensus binding site, pYXNX [17]. Peptide-binding
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Figure 9
Phosphorylated peptides based on the sequence around Y239 and
Y240 bind specific phosphotyrosine-containing proteins in lysates
from v-src-transformed cells. Biotinylated phosphopeptides based on
the sequence around Y239 and Y240 immobilized on streptavidin–
Sepharose were incubated with lysates from v-src-transformed
fibroblasts. Bound proteins were analyzed by immunoblotting with an
anti-pY monoclonal antibody. Lysis buffer was incubated with the
doubly phosphorylated peptide as a negative control (pY-pY, lane 1);
cell lysates were incubated with the unphosphorylated peptide (Y-Y,
lane 2), a peptide phosphorylated on Y239 (pY-Y, lane 3), a peptide
phosphorylated on Y240 (Y-pY, lane 4) and a peptide phosphorylated
on both tyrosine residues (pY-pY, lane 5). 
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studies show that both the Y239 mono-phosphorylated
and the di-phosphorylated peptides can bind to Grb2
present in cell lysates. The unphosphorylated peptide or
the peptide phosphorylated on Y240 did not bind to Grb2.
In vivo, wild-type HA-tagged Shc bound strongly to Grb2,
but mutant Shc proteins in which Y239 and Y240 had been
changed, either individually or together, to phenylalanine
demonstrated a strongly reduced ability to associate with
Grb2, suggesting that Y239 constitutes a major Grb2
binding site. It not clear why the F240 mutant binds Grb2
with greatly reduced affinity compared with the wild-type
protein in vivo. It is possible that the phenylalanine at the
240 position interferes with Grb2 recognition. Alterna-
tively, Y239 may be phosphorylated less efficiently when
it is followed by phenylalanine, perhaps because the
protein-tyrosine kinase that phosphorylates Y239 prefer-
entially recognizes this site in the context of a phosphoty-
rosine at position 240. A third possibility is that the
double-phosphorylated site has a higher affinity for the
Grb2 SH2 domain. With this in mind, it is of interest to
note that adjacent tyrosine residues followed by an
asparagine are present in the Drosophila and Caenorhabditis
elegans homologs of the EGF receptor, DER and Let23
[29,30]. Both receptor protein-tyrosine kinases have been
shown genetically to interact with Grb2 [31–34]. A YYN
motif is also present in the recently described Daughter-
of-Sevenless (Dos) protein, which contains a pleckstrin
homology domain [35]; both Dos and Drk, the Drosophila
homolog of Grb2, are required for efficient signalling
downstream of Sevenless. 
The presence of two tyrosine residues within one SH2
binding site raises the possibility of signal integration. It is
possible that complete phosphorylation of these two sites
depends on the activation of two different protein-tyrosine
kinases; activation of the first kinase would result in phos-
phorylation of one of the two tyrosine residues, creating a
phosphorylation site for the second kinase. Thus, complete
phosphorylation of this site may result from activation of
two signalling pathways. In this context, it is of interest
that, in vitro, peptides phosphorylated on Y239 appear to
bind a tyrosine-phosphorylated protein that is not bound
by the doubly phosphorylated peptide. Conversely, the
doubly phosphorylated peptide appears to bind to tyrosine
phosphorylated proteins that are not bound by peptides
phosphorylated on Y239 alone, whereas both peptides bind
Grb2. This suggests that different signalling pathways
might be activated downstream of Shc depending on the
phosphorylation of Shc at the Y239 and Y240 sites (Fig.
10). We are currently investigating the proteins that inter-
act with phosphorylated Y239 and Y240. Their identifica-
tion may provide further insights in the role of Shc during
signal transduction. 
Conclusions
Shc polypeptides are general substrates for protein-tyro-
sine kinases that become activated in response to a
variety of extracellular stimuli. Analysis of Shc tyrosine-
phosphorylation has been limited to the characterization
of Y317. Here, we have identified two novel tyrosine
phosphorylation sites, Y239 and Y240. These twin tyro-
sine residues are phosphorylated in vitro by purified Src
kinase, and in vivo in v-src-transformed and EGF-stimu-
lated cells. These novel sites are highly phosphorylated in
vivo, and both tyrosine residues are frequently phospho-
rylated in the same polypeptide. The Y239/240 Shc sites
are highly conserved in evolution, suggesting that they
are of physiological importance. 
Y239 is present within a consensus-binding site for the
Grb2 SH2 domain, and phosphorylation of Shc at both tyro-
sine residues is important for its association with Grb2 in
vivo. This raises the possibility that the Grb2 SH2 domain
may recognize sites that contain two phosphorylated tyro-
sine residues. Phosphopeptides based on the sequence
around Y239/240 bind Grb2 and several tyrosine-phospho-
rylated proteins in lysates of v-src-transformed cell. These
data suggest that these phosphorylation sites may function
as binding sites for one or more signalling proteins. Their
identification may lead to further understanding of Shc’s
role in normal and malignant signal transduction.
Materials and methods
Cells lines and antibodies
HER14 human EGF receptor overexpressing NIH3T3 cells [36] were
grown in Dulbecco-Vogt modified Eagles medium (DMEM) containing
10 % fetal bovine serum (FBS) and 400 mg ml–1 G418; S7A v-src-
transformed Rat-2 cells [37] were grown in DMEM containing 10 %
FBS; v-src-transformed embryonic fibroblasts were grown in DMEM
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Figure 10
Shc contains three tyrosine phosphorylation
sites in the proline-rich CH1 region — Y239
and Y240 identified here, and Y317 identified
previously [15]. Both the tandem
phosphorylation sites and Y317 contribute to
Grb2 binding. Y239/240 appear to be
involved in the interaction with a number of
additional phosphotyrosine-containing
proteins in v-src-transformed cells. 
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containing 5 % calf serum (CS); and COS1 cells [38] were grown in
DMEM containing 10 % CS. Polyclonal anti-Shc [7] and anti-pY [39]
sera were raised as described. Polyclonal anti-Grb2 serum C-23, mono-
clonal anti-pY 4G10, and monoclonal anti-HA 12CA5 were purchased
from Santa Cruz Biotechnology (Santa Cruz, California), UBI (Lake
Placid, New York), and Babco (Richmond, California), respectively.
GST fusion proteins
GST–Shc1–225 and GST–Shc1–307 are identical to GST–ShcB and
GST–ShcC [8]. GST–Shc280–473 is identical to GST–Shc+ and con-
tains p52Shc residues 280–473 [15]. The GST–Grb2 SH2 fusion
protein has been described before [16]. Mutants were generated using
a PCR-based strategy; mutant cDNA fragments were sequenced to
ensure fidelity and cloned back into the pGEX constructs. Fusion pro-
teins were induced and purified as described before [8].
Expression of wild-type and mutant HA-tagged Shc
polypeptides in mammalian cells
Wild-type and mutant human Shc cDNAs were cloned into the mam-
malian expression vector pcDNA3, a Kozak consensus sequence for
initiation of protein synthesis and a sequence encoding the HA epitope
starting with a methionine, were linked in frame by a sequence encod-
ing 13 amino acids to the Shc cDNA starting at the first residue of the
52 kDa isoform. COS1 cells at 50 % confluency were transfected with
5 mg pcDNA3 HA-Shc with or without 1 mg v-src cloned into pECE;
transfections were carried out using Lipofectin and Optimem (Gibco-
BRL, Burlington, Ontario L7P 1A1) according to manufacturers direc-
tions. Cells were lysed 72 h after transfection. 
Immunoprecipitation, peptide-affinity purification and
immunoblotting
Cells were grown to subconfluence on 10 cm tissue culture dishes. If
cells were to be stimulated with EGF, they were starved for 14–16 h in
DMEM containing 0.5 % FBS and 20 mM Hepes (pH 7.2). Control
cells or cells stimulated with 100 ng ml–1 EGF for 5 min at 37 °C were
lysed in PLC-lysis buffer and immunoprecipitations were carried out
exactly as described before [8]. To test for binding of phosphotyrosine-
containing proteins to phosphopeptides, PLC lysates were incubated
with biotinylated peptides that had been immobilized on streptavidin–
Sepharose beads. Sepharose beads were collected by centrifugation
and washed 4 times with PLC-lysis buffer. Immunoprecipitates were
boiled for 3 min in 62.5 M Tris–Cl (pH 6.8), 10 % glycerol, 5 % b-mer-
captoethanol, 5 mM DTT, 2.3 % SDS, and 0.025 % bromophenol blue
(SDS-sample buffer) and resolved by SDS–PAGE. Peptide bound pro-
teins were eluted with 100 mM triethylamine, boiled in SDS-sample
buffer, and resolved by SDS–PAGE. Transfer to PVDF membranes and
immunoblotting were carried out as described [8].
Phosphoamino-acid analysis and tryptic phosphopeptide
mapping
Cells were grown to confluence on 10 cm plates, starved in serum-free
medium if necessary, and labeled for 4 h in 5 ml phosphate-free DMEM
containing 0.5 % dialyzed FBS and 1 mCi ml–1 32P-orthophosphate. 
v-Src-transformed cells were labeled in medium containing 5 % dia-
lyzed FBS. Cells were rinsed twice with ice cold phosphate-buffered
saline (PBS) and lysed in 1 ml PLC lysis buffer per 10 cm tissue culture
dish. Shc proteins were isolated by immunoprecipitation with anti-Shc
serum or anti-HA antibodies and resolved by SDS–PAGE. GST-fusion
proteins were immobilized on glutathione–agarose phosphorylated in
vitro by incubation with purified v-Src kinase (Oncogene Science,
Cambridge, Massuchusetts) and g-[32P]ATP in 25 mM Hepes (pH 7.2),
5 mM MnCl2, 5 mM MgCl2 and 1 mM DTT for 30 min at 30 °C. Follow-
ing phosphorylation, the GST-fusion proteins bound to glutathione–
agarose were washed twice with PLC-LB and samples were resolved
by SDS–PAGE. For phosphopeptide mapping, proteins were recov-
ered from the dried gel after autoradiography, concentrated by TCA
precipitation and digested with trypsin as described [40]. Tryptic
digests were resolved by electrophoresis at 1000 V for 30 min at
pH 1.9 and chromatography in phosphochromobuffer. Phosphopeptides
were visualized by autoradiography. For phosphoamino-acid analysis,
proteins were hydrolyzed in 6 M HCl for 60 min at 110 °C after transfer
to PVDF membrane or after isolation from the dried gel as described
[40]. For phosphoamino-acid analysis of transiently expressed HA-
tagged Shc, proteins were transferred to PVDF membranes; to reduce
background, most phosphopeptides were eluted from the membrane
during digestion with trypsin before acid hydrolysis. The phosphopeptide
that gives rise to the di-phosphopeptide (pY-pY) following acid hydrolysis
is not eluted from the membrane during digestion with trypsin. 
Phosphopeptides were synthesized as described [41]. A biotin residue
was added to the amino-terminal end of each peptide during the syn-
thesis through addition of Fmoc-e-aminocaproic acid (Bachem Bio-
science, Torrance, California), followed by piperidine deprotection and
the direct incorporation of biotin, predissolved in a minimal volume of
DMSO, using HBTU activation. Cleavage of the peptide from the resin
and deprotection was achieved through a 90 min incubation at room
temperature in trifluoroacetic acid (10 ml) and a scavenger mixture
composed of water, thioanisole, 1,2–ethanedithiol (5.0:0.2:0.1 % by
volume) and solid phenol (75 mg). The product was precipitated with
cold t-butyl ethyl ether, collected by centrifugation and purified using
reverse phase HPLC. The authenticity of the phosphopeptides were
confirmed by amino-acid analysis and mass spectroscopy. 
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